Soluble Flt1 and placental growth factor are novel determinants of newborn thyroid (dys)function: The generation R study

Journal of Clinical Endocrinology and Metabolism

Volumn 99, Issue 9, 2014, Pages E1627-E1634

  Korevaar, Tim I M ^a   Steegers, Eric A P ^b   Schalekamp Timmermans, Sarah ^a,b   Ligthart, S ^a   De Rijke, Yolanda B ^a,b   Visser, W Edward ^a   Visser, Willy ^b   De Muinck Keizer Schrama, Sabine M P F ^b   Hofman, Albert ^a   Hooijkaas, Herbert ^a   Bongers Schokking, Jacoba J ^b   Russcher, Henk ^b   Tiemeier, Henning ^b   Jaddoe, Vincent W V ^a,b   Visser, Theo J ^a   Medici, Marco ^a   Peeters, Robin P ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b SOPHIA CHILDREN S HOSPITAL   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

PLACENTAL GROWTH FACTOR; SOLUBLE FMS LIKE TYROSINE KINASE 1; THYROTROPIN; UNCLASSIFIED DRUG; VASCULOTROPIN RECEPTOR 1; FLT1 PROTEIN, HUMAN; PLACENTA PROTEIN; THYROXINE;

ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE ASSOCIATION; FEEDBACK SYSTEM; FEMALE; FETUS; FREE THYROXINE INDEX; GENETIC RISK; GESTATIONAL AGE; HIGH RISK POPULATION; HUMAN; HYPERTHYROIDISM; HYPERTHYROTROPINEMIA; HYPOTHYROIDISM; HYPOTHYROXINEMIA; MALE; MENDELIAN RANDOMIZATION ANALYSIS; NEWBORN; POPULATION RESEARCH; PREDICTIVE VALUE; PREVALENCE; PROSPECTIVE STUDY; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; THYROID DISEASE; THYROID FUNCTION; THYROTROPIN BLOOD LEVEL; UMBILICAL CORD BLOOD; BLOOD; EMBRYOLOGY; FETUS BLOOD; PATHOPHYSIOLOGY; PHYSIOLOGY; PREGNANCY; RISK ASSESSMENT; SOLUBILITY; THYROID GLAND;

FEEDBACK, PHYSIOLOGICAL; FEMALE; FETAL BLOOD; GESTATIONAL AGE; HUMANS; HYPERTHYROIDISM; HYPOTHYROIDISM; INFANT, NEWBORN; MALE; PREGNANCY; PREGNANCY PROTEINS; RISK ASSESSMENT; SOLUBILITY; THYROID GLAND; THYROTROPIN; THYROXINE; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-1;

EID: 84907190308     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2014-1884     Document Type: Article

References (51)

1. Burrow GN, Fisher DA, Larsen PR. Maternal and fetal thyroid function. N Engl J Med. 1994;331: 1072-1078.
2. Fisher DA, Klein AH. Thyroid development and disorders of thyroid function in the newborn. N Engl J Med. 1981;304: 702-712.
3. HumeR, Simpson J, Delahunty C, et al.Humanfetal and cord serum thyroid hormones: Developmental trends and interrelationships. J Clin Endocrinol Metab. 2004;89: 4097-4103.
4. Thorpe-Beeston JG, Nicolaides KH, Felton CV, Butler J, McGregor AM. Maturation of the secretion of thyroid hormone and thyroidstimulating hormone in the fetus.NEngl JMed. 1991;324: 532-536.
5. Vulsma T, Gons MH, de Vijlder JJ. Maternal-fetal transfer of thyroxine in congenital hypothyroidism due to a total organification defect or thyroid agenesis. N Engl J Med. 1989;321: 13-16.
6. Mortimer RH, Galligan JP, Cannell GR, Addison RS, Roberts MS. Maternal to fetal thyroxine transmission in the human term placenta is limited by inner ring deiodination. J Clin Endocrinol Metab. 1996; 81: 2247-2249.
7. Momotani N, Iwama S, Momotani K. Neurodevelopment in children born to hypothyroid mothers restored to normal thyroxine (T4) concentration by late pregnancy in Japan: No apparent influence of maternal T4 deficiency. J Clin Endocrinol Metab. 2012;97: 1104-1108.
8. Berbel P, Navarro D, Ausó E, et al. Role of late maternal thyroid hormones in cerebral cortex development: An experimental model for human prematurity. Cereb Cortex. 2010;20: 1462-1475.
9. Williams FL, Watson J, Ogston SA, Visser TJ, Hume R, Willatts P. Maternal and umbilical cord levels of T4, FT4, TSH, TPOAb, and TgAb in term infants and neurodevelopmental outcome at 5.5 years. J Clin Endocrinol Metab. 2013;98: 829-838.
10. Shields BM, Knight BA, Hill A, Hattersley AT, Vaidya B. Fetal thyroid hormone level at birth is associated with fetal growth. J Clin Endocrinol Metab. 2011;96: E934-E938.
11. Reuss ML, Paneth N, Pinto-Martin JA, Lorenz JM, Susser M. The relation of transient hypothyroxinemia in preterm infants to neurologic development at two years of age. N Engl J Med. 1996;334: 821-827.
12. Maglione D, Guerriero V, Viglietto G, Delli-Bovi P, Persico MG. Isolation of a human placenta cDNA coding for a protein related to the vascular permeability factor. Proc Natl Acad Sci USA. 1991;88: 9267-9271.
13. Levine RJ, Maynard SE, Qian C, et al. Circulating angiogenic factors and the risk of preeclampsia. N Engl J Med. 2004;350: 672-683.
14. Thadhani R, Mutter WP, Wolf M, et al. First trimester placental growth factor and soluble fms-like tyrosine kinase 1 and risk for preeclampsia. J Clin Endocrinol Metab. 2004;89: 770-775.
15. Sunderji S, Gaziano E, Wothe D, et al. Automated assays for sVEGF R1 and PlGF as an aid in the diagnosis of preterm preeclampsia: A prospective clinical study. Am J Obstet Gynecol. 2010;202: 40.e1- e7.
16. Verlohren S, Galindo A, Schlembach D, et al. An automated method for the determination of the sFlt-1/PIGF ratio in the assessment of preeclampsia. Am J Obstet Gynecol. 2010;202: 161.e1-161.e11.
17. Coolman M, Timmermans S, de Groot CJ, et al. Angiogenic and fibrinolytic factors in blood during the first half of pregnancy and adverse pregnancy outcomes. Obstet Gynecol. 2012;119: 1190-1200.
18. Yang Y, Zhang Y, Cao Z, et al. Anti-VEGF- and anti-VEGF receptor- induced vascular alteration in mouse healthy tissues. Proc Natl Acad Sci USA. 2013;110: 12018-12023.
19. Kamba T, Tam BY, Hashizume H, et al. VEGF-dependent plasticity of fenestrated capillaries in the normal adult microvasculature.AmJ Physiol Heart Circ Physiol. 2006;290: H560-H576.
20. Makita N, Iiri T. Tyrosine kinase inhibitor-induced thyroid disorders: A review and hypothesis. Thyroid. 2013;23: 151-159.
21. Jaddoe VW, van Duijn CM, Franco OH, et al. The Generation R Study: Design and cohort update 2012. Eur J Epidemiol. 2012;27: 739-756.
22. Medici M, de Rijke YB, Peeters RP, et al. Maternal early pregnancy and newborn thyroid hormone parameters: The GenerationRstudy. J Clin Endocrinol Metab. 2012;97: 646-652.
23. van den Hooven EH, Pierik FH, de Kluizenaar Y, et al. Air pollution exposure and markers of placental growth and function: The generation R study. Environ Health Perspect. 2012;120: 1753-1759.
24. Männistö T, Surcel HM, Bloigu A, et al. The effect of freezing, thawing, and short- and long-term storage on serum thyrotropin, thyroid hormones, and thyroid autoantibodies: Implications for analyzing samples stored in serum banks. Clin Chem. 2007;53: 1986-1987.
25. Law LW, Sahota DS, Chan LW, Chen M, Lau TK, Leung TY. Effect of long-term storage on placental growth factor and fms-like tyrosine kinase 1 measurements in samples from pregnant women. J Matern Fetal Neonatal Med. 2010;23: 1475-1480.
26. JaddoeVW,Bakker R, van DuijnCM,et al. The GenerationRStudy Biobank: A resource for epidemiological studies in children and their parents. Eur J Epidemiol. 2007;22: 917-923.
27. Verburg BO, Steegers EA, De Ridder M, et al. New charts for ultrasound dating of pregnancy and assessment of fetal growth: Longitudinal data from a population-based cohort study. Ultrasound Obstet Gynecol. 2008;31: 388-396.
28. Korevaar TI, Medici M, de Rijke YB, et al. Ethnic differences in maternal thyroid parameters during pregnancy: The Generation R Study. J Clin Endocrinol Metab. 2013;98: 3678-3686.
29. Korevaar TI, Schalekamp-Timmermans S, de Rijke YB, et al. Hypothyroxinemia and TPO-antibody positivity are risk factors for premature delivery: The Generation R study. J Clin Endocrinol Metab. 2013;98: 4382-4390.
30. Sterne JA, White IR, Carlin JB, et al. Multiple imputation for missing data in epidemiological and clinical research: Potential and pitfalls. BMJ. 2009;338: B2393.
31. Lawlor DA, Harbord RM, Sterne JA, Timpson N, Davey Smith G. Mendelian randomization: Using genes as instruments for making causal inferences in epidemiology. Stat Med. 2008;27: 1133-1163.
32. Porcu E, Medici M, Pistis G, et al.Ameta-analysis of thyroid-related traits reveals novel loci and gender-specific differences in the regulation of thyroid function. PLoS Genet. 2013;9: E1003266.
33. Chan LY, Fok WY, Sahota D, Lau TK. Cord blood thyroid-stimulating hormone level and risk of acidosis at birth. Eur J Obstet Gynecol Reprod Biol. 2006;124: 173-177.
34. Calaciura F, MottaRM,Miscio G, et al. Subclinical hypothyroidism in early childhood: A frequent outcome of transient neonatal hyperthyrotropinemia. J Clin Endocrinol Metab. 2002;87: 3209-3214.
35. Leonardi D, Polizzotti N, Carta A, et al. Longitudinal study of thyroid function in children with mild hyperthyrotropinemia at neonatal screening for congenital hypothyroidism. J Clin Endocrinol Metab. 2008;93: 2679-2685.
36. Oken E, Braverman LE, Platek D, Mitchell ML, Lee SL, Pearce EN. Neonatal thyroxine, maternal thyroid function, and child cognition. J Clin Endocrinol Metab. 2009;94: 497-503.
37. Makita N, Miyakawa M, Fujita T, Iiri T. Sunitinib induces hypothyroidism with a markedly reduced vascularity. Thyroid. 2010;20: 323-326.
38. Gobble RM, Groesch KA, Chang M, Torry RJ, Torry DS. Differential regulation of human PlGF gene expression in trophoblast and nontrophoblast cells by oxygen tension. Placenta. 2009;30: 869-875.
39. Nevo O, Soleymanlou N,WuY, et al. Increased expression of sFlt-1 in in vivo and in vitro models of human placental hypoxia is mediated by HIF-1.AmJ Physiol Regul Integr Comp Physiol. 2006;291: R1085-R1093.
40. Simonides WS, Mulcahey MA, Redout EM, et al. Hypoxia-inducible factor induces local thyroid hormone inactivation during hypoxic- ischemic disease in rats. J Clin Invest. 2008;118: 975-983.
41. Thomas CP, Andrews JI, Raikwar NS, et al.Arecently evolved novel trophoblast-enriched secreted form of fms-like tyrosine kinase-1 variant is up-regulated in hypoxia and preeclampsia. J Clin Endocrinol Metab. 2009;94: 2524-2530.
42. Kappers MH, van Esch JH, Smedts FM, et al. Sunitinib-induced hypothyroidism is due to induction of type 3 deiodinase activity and thyroidal capillary regression. J Clin Endocrinol Metab. 2011;96: 3087-3094.
43. Zamudio S, Kovalenko O, Echalar L, et al. Evidence for extraplacental sources of circulating angiogenic growth effectors in human pregnancy. Placenta. 2013;34: 1170-1176.
44. Huang SA, DorfmanDM,Genest DR, Salvatore D, Larsen PR. Type 3 iodothyronine deiodinase is highly expressed in the human uteroplacental unit and in fetal epithelium. J Clin Endocrinol Metab. 2003;88: 1384-1388.
45. Wong E, Rosen LS, Mulay M, et al. Sunitinib induces hypothyroidism in advanced cancer patients and may inhibit thyroid peroxidase activity. Thyroid. 2007;17: 351-355.
46. Remy S, Govarts E, Bruckers L, et al. Expression of the sFLT1 gene in cord blood cells is associated to maternal arsenic exposure and decreased birth weight. Plos One. 2014;9: E92677.
47. Rooman RP, Du Caju MV, De Beeck LO, Docx M, Van Reempts P, Van Acker KJ. Low thyroxinaemia occurs in the majority of very preterm newborns. Eur J Pediatr. 1996;155: 211-215.
48. Murphy N,HumeR, van Toor H, et al. The hypothalamic-pituitarythyroid axis in preterm infants; changes in the first 24 hours of postnatal life. J Clin Endocrinol Metab. 2004;89: 2824-2831.
49. Williams FL, Mires GJ, Barnett C, et al. Transient hypothyroxinemia in preterm infants: The role of cord sera thyroid hormone levels adjusted for prenatal and intrapartum factors. J Clin Endocrinol Metab. 2005;90: 4599-4606.
50. Boutsikou T, Malamitsi-Puchner A, Economou E, Boutsikou M, Puchner KP, Hassiakos D. Soluble vascular endothelial growth factor receptor-1 in intrauterine growth restricted fetuses and neonates. Early Hum Dev. 2006;82: 235-239.
51. Loui A, Eilers E, Strauss E, Pohl-Schickinger A, Obladen M, Koehne P. Vascular endothelial growth factor (VEGF) and soluble VEGF receptor 1 (sFlt-1) levels in early and mature human milk from mothers of preterm versus term infants. J Hum Lact. 2012;28: 522-528.